Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pediatric Relapsed”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT00941928
What this trial is testing

Haploidentical Natural Killer (NK) Cells With Epratuzumab for Relapsed Acute Lymphoblastic Leukemia (ALL)

Who this might be right for
LeukemiaPediatric Cancer
M.D. Anderson Cancer Center 2
Not applicableLooking for participantsNCT06649253
What this trial is testing

Childhood B-acute Lymphoblastic Leukaemia and Role of CD9 Gene Regulation in Relapse

Who this might be right for
Leukemia, Lymphoblastic, Acute, Pediatric
Rennes University Hospital 50
Early research (Phase 1)Study completedNCT01231919
What this trial is testing

MK2206 in Treating Younger Patients With Recurrent or Refractory Solid Tumors or Leukemia

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAcute Leukemias of Ambiguous LineageAcute Myeloid Leukemia/Transient Myeloproliferative Disorder+48 more
National Cancer Institute (NCI) 45
Early research (Phase 1)Temporarily pausedNCT00077493
What this trial is testing

BL22 Immunotoxin In Treating Young Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia or Non-Hodgkin's Lymphoma

Who this might be right for
LeukemiaLymphoma
MedImmune LLC 95
Early research (Phase 1)Ended earlyNCT01743807
What this trial is testing

Phase I Study of GNKG168 in Acute Lymphoblastic Leukemia and Acute Myelogenous Leukemia

Who this might be right for
Relapsed Acute Lymphoblastic LeukemiaRelapsed Acute Myelogenous Leukemia
Therapeutic Advances in Childhood Leukemia Consortium 4
Post-approval studies (Phase 4)Ended earlyNCT02618109
What this trial is testing

Identification of New Immune Factors Specific of Relapse in Childhood B Lineage Acute Lymphoblastic Leukemia

Who this might be right for
B Acute Lymphoblastic LeukemiaLeukemia Relapse
University Hospital, Angers 119
Testing effectiveness (Phase 2)Study completedNCT02945800
What this trial is testing

Nab-Paclitaxel and Gemcitabine for Recurrent/Refractory Sarcoma

Who this might be right for
OsteosarcomaEwing SarcomaRhabdomyosarcoma+1 more
H. Lee Moffitt Cancer Center and Research Institute 59
Early research (Phase 1)Study completedNCT00053963
What this trial is testing

FR901228 in Treating Children With Refractory or Recurrent Solid Tumors or Leukemia

Who this might be right for
Blastic Phase Chronic Myelogenous LeukemiaChildhood Central Nervous System Germ Cell TumorChildhood Choroid Plexus Tumor+22 more
National Cancer Institute (NCI) 30
Early research (Phase 1)Looking for participantsNCT06609928
What this trial is testing

FH-FOLR1 Chimeric Antigen Receptor T Cell Therapy for Treating Pediatric Patients With Relapsed or Refractory Acute Myeloid Leukemia

Who this might be right for
Recurrent Childhood Acute Myeloid LeukemiaRefractory Childhood Acute Myeloid Leukemia
Fred Hutchinson Cancer Center 12
Testing effectiveness (Phase 2)Looking for participantsNCT05667506
What this trial is testing

CNCT19 Treatment in Children and Adolescent r/r ALL Patients(Pediatric)

Who this might be right for
B-cell Acute Lymphoblastic Leukemia
Juventas Cell Therapy Ltd. 47
Testing effectiveness (Phase 2)Study completedNCT00407433
What this trial is testing

Clinical Studies of Gemcitabine-Oxaliplatin

Who this might be right for
MedulloblastomaCentral Nervous System TumorsNeuroblastoma+1 more
Gustave Roussy, Cancer Campus, Grand Paris 156
Testing effectiveness (Phase 2)Active Not RecruitingNCT02028455
What this trial is testing

A Pediatric and Young Adult Trial of Genetically Modified T Cells Directed Against CD19 for Relapsed/Refractory CD19+ Leukemia

Who this might be right for
CD19+ Acute Leukemia
Seattle Children's Hospital 167
Early research (Phase 1)Study completedNCT00112645
What this trial is testing

Donor Stem Cell Transplant in Treating Young Patients With Relapsed or Refractory Solid Tumors

Who this might be right for
NeuroblastomaSarcomaUnspecified Childhood Solid Tumor, Protocol Specific
Milton S. Hershey Medical Center 10
Very early researchLooking for participantsNCT07490041
What this trial is testing

Exploratory Clinical Study on the Safety and Efficacy of Anti- CD19/BCMA CAR-NK Cell Injection for the Treatment of Refractory Pediatric Rheumatic Diseases

Who this might be right for
Rheumatic DiseasesPediatric Rheumatological Condition (i.e., Arthritis, SLE, Kawasaki's Disaese)Systemic Lupus Erythematosus (SLE)+1 more
The Children's Hospital of Zhejiang University School of Medicine 36
Testing effectiveness (Phase 2)Active Not RecruitingNCT03155620
What this trial is testing

Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial)

Who this might be right for
Advanced Malignant Solid NeoplasmAnn Arbor Stage III Non-Hodgkin LymphomaAnn Arbor Stage IV Non-Hodgkin Lymphoma+42 more
National Cancer Institute (NCI) 1,377
Testing effectiveness (Phase 2)Looking for participantsNCT06013618
What this trial is testing

Clinical Analysis of Naxitamab (hu3F8) in the Treatment of Pediatric High Risk or Refractory/ Relapsed Neuroblastoma

Who this might be right for
Neuroblastoma
Sun Yat-Sen University Cancer Center 120
Early research (Phase 1)Study completedNCT01321346
What this trial is testing

Panobinostat In Children With Refractory Hematologic Malignancies

Who this might be right for
Lymphoblastic Leukemia, Acute, ChildhoodMyelogenous Leukemia, Acute, ChildhoodHodgkin's Disease+1 more
Therapeutic Advances in Childhood Leukemia Consortium 30
Very early researchUnknownNCT05519384
What this trial is testing

Safety and Preliminary Efficacy of JK500 Cell Injection in Relapsed/Refractory Pediatric Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia, ChildhoodRelapsed LeukemiaRefractory Leukemia
Institute of Hematology & Blood Diseases Hospital, China 12
Testing effectiveness (Phase 2)Study completedNCT04145349
What this trial is testing

CAMPFIRE: A Study of Ramucirumab (LY3009806) in Children and Young Adults With Desmoplastic Small Round Cell Tumor

Who this might be right for
Desmoplastic Small Round Cell Tumor
Eli Lilly and Company 30
Early research (Phase 1)Ended earlyNCT01186328
What this trial is testing

EZN-3042 Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL)

Who this might be right for
Lymphoblastic Leukemia, AcuteLymphoblastic Leukemia, Acute, ChildhoodLeukemia, Lymphoblastic, Acute, T Cell+1 more
Therapeutic Advances in Childhood Leukemia Consortium 6
Next Page